We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Bayer Stops Worldwide Sales of Trasylol Pending Safety Data
Bayer Stops Worldwide Sales of Trasylol Pending Safety Data
November 9, 2007
Bayer is suspending global marketing of its clotting drug Trasylol as the FDA waits for additional data from a study that suggested the drug was associated with an increased risk of death.